Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer C Rönnlund, EG Sifakis, C Schagerholm, Q Yang, E Karlsson, X Chen, ... Breast Cancer Research 26 (1), 24, 2024 | 4 | 2024 |
PIK3CA mutations in endocrine-resistant breast cancer C Schagerholm, S Robertson, H Toosi, EG Sifakis, J Hartman Scientific Reports 14 (1), 12542, 2024 | 1 | 2024 |
Abstract PO3-16-04: Distribution of intrinsic subtypes in endocrine-resistant and endocrine-sensitive breast cancer C Schagerholm, S Robertson, E Karlsson, E Sifakis, J Hartman Cancer Research 84 (9_Supplement), PO3-16-04-PO3-16-04, 2024 | | 2024 |
Abstract PO5-13-02: BRCA mutational profiles of endocrine-resistant breast cancer E Karlsson, C Schagerholm, S Robertson, H Toosi, E Sifakis, J Hartman Cancer Research 84 (9_Supplement), PO5-13-02-PO5-13-02, 2024 | | 2024 |
Abstract PO4-01-05: The prognostic importance of biological pathway enrichment patterns in trastuzumab-treated early HER2-positive breast cancer C Rönnlund, Q Yang, C Schagerholm, T Foukakis, I Fredriksson, X Chen, ... Cancer Research 84 (9_Supplement), PO4-01-05-PO4-01-05, 2024 | | 2024 |
PIK3CA mutations in endocrine-resistant breast cancer C Schagerholm, S Robertson, B Holm, H Awier, H Toosi, E Sifakis, ... VIRCHOWS ARCHIV 481 (SUPPL 1), S42-S43, 2022 | | 2022 |
223P Gene expression profiles in endocrine-resistant breast cancer C Schagerholm, S Robertson, EG Sifakis, L Hases, C Williams, J Hartman Annals of Oncology 33, S640, 2022 | | 2022 |
Abstract P1-07-07: Endoresist: Prognostic and predictive gene profiles in endocrine-resistant breast cancers C Schagerholm, S Robertson, B Holm, K Lindberg, E Sifakis, L Hases, ... Cancer Research 82 (4_Supplement), P1-07-07-P1-07-07, 2022 | | 2022 |
Transcriptional profiling of endocrine resistant versus sensitive breast cancer uncovers gene expression programmes associated with therapeutic response C Schagerholm, S Robertson, K Govindasamy-Muralidharan, J Lovrot, ... VIRCHOWS ARCHIV 473, S30-S30, 2018 | | 2018 |